Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women With Metastatic Breast Cancer
Latest Information Update: 26 Jun 2023
At a glance
- Drugs Fulvestrant (Primary) ; Anastrozole
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- 06 Jun 2023 Results assessing Comparing the prognostic and predictive utility of serum thymidine kinase 1 and CA 15-3 in patients with hormone receptor positive metastatic breast cancer starting first-line endocrine therapy in SWOG S0226 presented at the 59th Annual Meeting of the American Society of Clinical Oncology
- 01 May 2023 Results published in the Biomarkers
- 14 Sep 2021 Primary endpoint (Overall survival) has been met according to the results published in the Clinical Cancer Research